Artiva Biotherapeutics Ratios (2023-2025) | ARTV

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -323.56%42.13%-484.55%-5,514.74%
EBIT Margin -338.12%40.56%-509.36%-5,773.71%
EBITDA Margin -319.04%42.85%-508.98%-5,603.19%
Operating Margin -338.12%40.56%-509.36%-5,773.71%
Net Margin -323.56%42.13%-484.55%-5,514.74%
FCF Margin -40.99%-481.32%-6,017.53%
Efficiency
Assets Average 150.75M217.59M200.42M180.33M159.13M
Equity Average -157.85M-156.73M-168.34M-182.88M4.95M193.82M177.71M158.91M139.13M
Invested Capital -164.25M-151.45M-162.01M-174.67M-191.10M201.00M186.64M168.78M149.04M129.22M
Asset Utilization Ratio 0.020.00
Leverage & Solvency
Equity Ratio -1.54-2.520.890.890.880.880.87
Valuation
Enterprise Value -53.70M-65.89M42.67M-48.20M73.09M-146.63M-185.43M-301.56M-256.30M-220.46M
Return Ratios
Return on Sales -3.24%0.42%-4.85%-55.15%-1.01%-22.00%-246.75%
Return on Capital Employed -0.44%-0.33%
Return on Assets -0.38%-0.28%-0.24%-0.18%-0.10%
Return on Equity 0.15%0.16%-11.56%-0.32%-0.27%-0.21%-0.12%